文献速递认知障碍与痴呆帕金森病与运动障碍

路易体痴呆中β-淀粉样蛋白的临床与纹状体多巴胺转运体预测因素

Clinical and striatal dopamine transporter predictors of β-amyloid in dementia with Lewy bodies.
PubMed 文献 · Neurology · 2020-02-21

研究纳入51例路易体痴呆患者,按脑淀粉样斑块负荷评分分为Aβ阴性组20例和Aβ阳性组31例,比较两组多巴胺转运体活性、神经心理和神经精神症状。结果显示Aβ阳性组诊断年龄更轻、注意和视空间功能更差、焦虑比例和总神经精神负担更高,且前壳核和腹侧纹状体多巴胺转运体活性更低。

要点

  • Aβ阳性的路易体痴呆患者诊断年龄更轻,注意和视空间功能更差。
  • Aβ阳性组焦虑比例和总神经精神负担更高。
  • Aβ阳性组前壳核和腹侧纹状体多巴胺转运体活性更低。

核心结论

  • 路易体痴呆中Aβ沉积与更年轻的诊断年龄、更高的认知和神经精神负担以及降低的多巴胺转运体活性相关。
  • 评估临床特征和多巴胺转运体活性可预测路易体痴呆中Aβ的存在。

研究设计与样本

  • 连续招募51例路易体痴呆患者,均在6个月内完成神经心理测试、神经精神量表评估、脑MRI、18F-FP-CIT PET和18F-florbetaben PET。
  • 根据脑淀粉样斑块负荷评分将患者分为Aβ阴性组20例和Aβ阳性组31例。

主要发现

  • 与Aβ阴性组相比,Aβ阳性组诊断年龄更轻(p=0.017)。
  • Aβ阳性组注意功能(p=0.028)和视空间功能(p=0.006)更差。
  • Aβ阳性组焦虑比例(p=0.006)和总神经精神负担(p=0.013)更高。
  • 校正年龄、性别和教育年限后,Aβ阳性组前壳核(p=0.015)和腹侧纹状体(p=0.006)多巴胺转运体活性更低。
  • 腹侧纹状体多巴胺转运体活性降低与路易体痴呆中的焦虑和总神经精神负担显著相关。

临床怎么用

  • 对路易体痴呆患者评估临床特征和多巴胺转运体活性有助于预测Aβ沉积的存在。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the relationship between β-amyloid (Aβ) deposition and striatal dopamine depletion, cognitive functions, and neuropsychiatric symptoms in dementia with Lewy bodies (DLB). METHODS: We consecutively recruited 51 patients with DLB who had undergone a neuropsychological test, Neuropsychiatric Inventory assessment, brain MRI, N-(3-[18F]fluoropropyl)-2β-carbon ethoxy-3β-(4-iodophenyl) PET, and 18F-florbetaben PET within 6 months. The patients were divided into Aβ-negative (DLB-Aβ-, n = 20) and Aβ-positive (DLB-Aβ+, n = 31) groups according to the brain amyloid plaque load score. We performed comparative analyses of dopamine transporter (DAT) activity, neuropsychological profile, and neuropsychiatric symptoms between the 2 groups. RESULTS: Compared to the DLB-Aβ- group, the DLB-Aβ+ group had a younger age at diagnosis (p = 0.017), poorer performance in attention (p = 0.028) and visuospatial (p = 0.006) functions, and higher proportion of anxiety (p = 0.006) and total neuropsychiatric burden (p = 0.013). Those in the DLB-Aβ+ group also had lower DAT activity in the anterior putamen (p = 0.015) and ventral striatum (p = 0.006) regardless of age, sex, and years of education. In addition, lower DAT activity in the ventral striatum was significantly associated with anxiety and total neuropsychiatric burden in DLB. CONCLUSIONS: This study demonstrated that Aβ deposition in DLB is associated with diagnosis at a younger age, higher cognitive and neuropsychiatric burden, and decreased DAT activity, suggesting that evaluation of clinical features and DAT activity can predict the presence of Aβ in DLB.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Yoo HS, Lee S, Chung SJ, et al. Clinical and striatal dopamine transporter predictors of β-amyloid in dementia with Lewy bodies. Neurology. 2020. PMID: 32086384. doi:10.1212/WNL.0000000000009168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。